期刊文献+

葡萄糖激酶M197V突变的活化机理研究 被引量:1

Activation Mechanism Study of Glucokinase by M197V Mutation
原文传递
导出
摘要 葡萄糖激酶(glucokinase,GK)催化葡萄糖转变为6-磷酸葡萄糖,是糖代谢的第一步,所以GK活性异常在糖代谢紊乱的发生发展中起着重要作用.对青年型早发糖尿病(maturity-onset diabetes of the young 2,MODY 2)型和高胰岛素性低血糖症(persistent hyperinsulinemic hypoglycemia of infancy,PHHI)型的深入研究证实了GK活性改变与糖尿病的发生有关.为了研究GK活性改变的机理,通过分子动力学模拟和隐性溶剂的自由能的计算对GK的单点突变M197V(Met197→Val)进行了理论研究.通过GK的Cα原子均方根浮动变化(Root mean square fluctuation,RMSF)和动态相关性矩阵(Dynamic cross-correlation matrices,DCCM)分析,显示M197V突变导致GK在活化状态的构象更加稳定.通过包结自由能分析,表明M197V突变可以增加GK对葡萄糖的包结亲合性,并且理论预测突变前后的相对包结自由能差值和已有的实验结果非常吻合.研究结果很好地从原子水平解释了GK的M197V突变的活化机理. Glucokinase (GK) is a glycolic enzyme that catalyzes the phosphorylation of glucose to glucose-6-phosphate in the first step of glycolysis. Thus alteration in GK activity plays an important role in abnormal glycemia. A great deal of research about maturity-onset diabetes of the young 2 (MODY 2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) confirmed that the change of GK activity was associated with diabetes. The explicit molecular dynamics simulations and implicit solvent binding free-energy calculations were investigated to understand the activation mechanism of OK point mutation M197V (Met^197 →Val). The root mean square fluctuation (RMSF) and dynamic cross-correlation matrices (DCCM) conformation analysis showed that GK M197V mutation resulted in a more stable active conformation. The binding free-energy analysis demonstrated that the GK M197V mutation increased its binding affinity with glucose. The difference of binding free-energy between wild-type (WT) GK and M197V GK was in well agreement with previous experimental results. Our results can interpret the active mechanism of GK M197V mutation from the atom level perfectly.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2011年第4期405-410,共6页 Acta Chimica Sinica
基金 江苏省农机局科研启动基金(No.gxz10008)资助项目
关键词 葡萄糖激酶 分子动力学 DCCM MM—PBSA glucokinase molecular dynamics DCCM MM-PBSA
  • 相关文献

参考文献1

二级参考文献30

  • 1胡建平,孙庭广,陈慰祖,王存新.谷氨酰胺结合蛋白的分子动力学模拟和自由能计算[J].化学学报,2006,64(20):2079-2085. 被引量:12
  • 2马国正,蒋勇军,俞庆森.诺氟沙星-DNA复合物的分子动力学模拟[J].化学学报,2007,65(4):284-288. 被引量:6
  • 3Szejtli, J. Chem. Rev. 1998, 98, 1743.
  • 4Hedges, A. R. Chem. Rev. 1998, 98, 2035.
  • 5Wallimann, P.; Marti, T.; Frer, A.; Diederich, F. Chem. Rev. 1997, 97, 1567.
  • 6Sadlej-Sosnowska, N. J. Inclusion Phenom. Mol. Recognit. Chem. 1997, 27, 31.
  • 7Bednarek, E.; Bocian, W.; Poznanski, J.; Sitkowski, J.; Sadlej-Sosnowska, N.; Kozerski, L. J. Chem. Soc. Perkin Trans. 2 2002, 5, 999.
  • 8Thompson, D.; Larsson, J. A. J. Phys. Chem. B 2006, 110, 16640.
  • 9Yu, Y. M.; Chipot, C.; Cai, W. S.; Shao, X. G.J. Phys. Chem. B 2006, 110, 6372.
  • 10Bea, I.; Gotsev, M. G.; Ivanov, M. G.; Jaime, C.; Kollman, E A. J. Org. Chem. 2006, 71, 2056.

共引文献2

同被引文献18

  • 1FERRE T, RIU E, BOSCH F, et al. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver[J]. FASEBJ, 1996, 10(10):1213-1218.
  • 2NOGUEIRA F N, SANTOS M F, NICOLAU J. Influence of streptozotocin-induced diabetes on hexokinase activity of rat salivary glands [J]. J Physiol Biochem, 2005, 61(3):421-428.
  • 3KAMATA K, MITSUYA M, NISHIMURA T, et al. Structural basis for allosteric regulation of themonomeric allosteric enzyme human glucokinase [J]. Structure, 2004, 12 (3) : 429- 438.
  • 4VIONNET N, STOFFEL M, TAKEDA J, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insu- lin-dependent diabetes mellitus [J]. Nature, 1992, 356(6371) : 721-722.
  • 5GRIMSBY J, SARABU R, CORBETT W L, et al. Allosteric activators of glucokinase: potential role in diabetes therapy [J]. Science, 2003, 301(5631): 370-373.
  • 6FUTAMURA M, HOSAKA H, KADOTANI A, et al. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism [J]. J Biol Chem, 2006, 281(49) : 37668 -37674.
  • 7IINO T, TSUKAHARA D, KAMATA K, et al. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N thiazolyl benzamides as novel allosteric glucokinase activators [J]. Bioorg Med Chem, 2009, 17(7): 2733-2743.
  • 8NISHIMURA T, IINO T, MITSUYA M, et al. Identification of novel and potent 2 amino benzamide derivatives as allosteric glucokinase activators [J]. J Bioorg Med Chem Lett, 2009, 19(5): 1357-1360.
  • 9MATSCHINSKY F M. Assessing the potential of glucokinase activators in diabetes therapy: nature reviews drug discover y [J] Nat Rev Drug Discov, 2009, 8(5): 399-416.
  • 10ZHANG Jian, LIChen Jing, CHEN Kai Xian, et al. Conformational transition pathway in the allosteric process of human glucokinase [J]. ProcNatlAcad SciUSA, 2006, 103(36): 13368-13373.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部